Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions
Convenience: Typically administered every few months, injections eliminate the need for daily pills
BPC-157 also enhances growth hormone receptor expression in fibroblasts and promotes FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival during tissue repair processes
BPC-157 at PCAC: The First Chapter in a Larger Regulatory Debate Todays PCAC review of BPC-157 is only the first phase of a broader process
Flawless adhesion and removal
Periodontitis is more than a bacterial infectionits driven by immune and metabolic dysfunction, cellular aging, and inflammation